Latest news with #Emergent
Associated Press
18-04-2025
- Business
- Associated Press
Kevin Vilkin Joins Conservation International Board of Directors
AUSTIN, Texas, April 18, 2025 (GLOBE NEWSWIRE) -- Kevin Vilkin, co-founder of Emergent Strategic Partners, has been appointed to the Board of Directors of Conservation International, a leading global nonprofit dedicated to protecting nature for the benefit of people and the planet. As a board member, Vilkin will contribute his expertise in sustainable innovation and strategic partnerships to support the organization's mission of advancing conservation efforts worldwide. 'I have know Kevin for close to a decade,' said Peter Seligmann, Chairman of the Board of Conservation International. 'He brings the needed boldness of youth, as well as integrity, intelligence and humanity, to the great challenges that CI and all of our partners must overcome.' 'Joining the board of Conservation International is a privilege,' said Vilkin. 'The organization's work in preserving our planet's natural resources is more critical than ever. I am excited to help drive initiatives that create lasting environmental and economic impact.' About Conservation International Conservation International protects nature for the benefit of humanity. Through science, policy, fieldwork and finance, we spotlight and secure the most important places in nature for the climate, for biodiversity and for people. With offices in 30 countries and projects in more than 100 countries, Conservation International partners with governments, companies, civil society, Indigenous peoples and local communities to help people and nature thrive together. Go to for more, and follow our work on Conservation News, Facebook, Twitter, TikTok, Instagram and YouTube. About Kevin Vilkin Before launching Emergent, Vilkin founded and successfully exited his first business—a music events company—at the age of 21, helping shape the careers of global artists such as Mumford & Sons and the Zac Brown Band. He founded the Vanguard Program for Summit Series, connecting the world's most influential leaders, including Richard Branson, Ray Dalio, and Jeff Bezos. Vilkin currently serves as a Senior Advisor to Redaptive, and GoodLeap. He sits on the Board of Directors at Conservation International, is a member of Business Executives for National Security (BENS), and has been recognized as a Milken Young Leaders Circle and Forbes 30 Under 30 honoree. Additionally, he previously served as a Senior Advisor to TPG Growth. About Emergent Strategic Partners Emergent develops strategic partnerships that scale sustainable innovations for large enterprises. By connecting leading companies with emerging businesses, Emergent drives cost efficiencies and revenue growth while providing family offices with access to high-potential investment opportunities. Emergent partners' impact includes $2.2B in revenue generated, $2.8B in enterprise value created, and $1.3B in capital raised. Media Contact: Paul Orszag Emergent Strategic Partners [email protected] (661) 803-6617
Associated Press
17-03-2025
- Entertainment
- Associated Press
VISIT FLORIDA and Emergent Media Partner on Two Creator-Led Original Video Series
Emergent's proprietary creator network was leveraged to help scale social content creation EL SEGUNDO, Calif., March 17, 2025 /PRNewswire/ -- Emergent Media continues its successful partnership with VISIT FLORIDA with the debut of two new creator-led original video series, 'Wild About Florida,' and 'What's Up in Florida.' Developed and produced by Emergent Media and leveraging Emergent's proprietary creator network, these social-first, highly engaging series are designed to showcase the incredible nature and exciting events in the Sunshine State. 'With these new original video series, VISIT FLORIDA is celebrating the experience of Florida—the natural beauty, the wildlife, the cultural and social scene—in a new and innovative way. By centering Florida within the types of content that social audiences love to see and share, we're reaching new communities and driving genuine interest in Florida as the No. 1 destination in the U.S.' —Brett Laiken, Chief Marketing Officer, VISIT FLORIDA In 'Wild About Florida,' a duo of adventurous, engaging video creators explores the wilder sides of Florida, from snorkeling with manatees in Crystal River to horseback riding in Ocala to catching spiny lobsters in Biscayne Bay. For 'What's Up in Florida,' a key trend was leveraged—the significant rise in global travelers planning trips around events—to develop a creative, engaging series that showcases Florida's breadth of events and resonates with travelers and locals alike. Filmed in a social-endemic greenscreen format with a charismatic Floridian as its host, the monthly series spans the entire state, bringing awareness and driving interest in food and music festivals, cultural celebrations, and more. 'Emergent's lifestyle brands were incubated on social, so we have a deep understanding of the stories that engage and convert social audiences. Tapping into talent from our rapidly-growing creator network allows us to be nimble and efficient in producing those stories at scale, while maintaining a high bar for quality.' —Jennifer Klawin, Chief Business Officer, Emergent Media Emergent Media is a creator-led digital publisher and branded content studio. Powered by our global community of creators and informed by data and insights, we create and distribute content that delights consumers and drives results for brands.
Yahoo
13-03-2025
- Business
- Yahoo
Emergent signs financial investment agreement with Swiss Rockets
Emergent BioSolutions has entered a strategic financial investment agreement with Swiss Rockets to support infrastructure development, research and the expansion of the latter's biotech portfolio. Swiss Rockets is the parent company of Rocketvax. Alongside the investment, a strategic partnership is planned, positioning Emergent to spearhead the US manufacturing and commercialisation offerings for four of Rocketvax's pipeline candidates targeting cancer, autoimmune disorders and infectious diseases. One of these is a next-generation live-attenuated nasal spray SARS-CoV-2 vaccine. In animal studies, this vaccine has shown superior efficacy compared with messenger ribonucleic acid (mRNA) Covid-19 vaccines. Rocketvax had previously initiated a partnership by signing a letter of intent with the US National Institutes of Health (NIH) under the Project NextGen initiative, facilitating a clinical trial to investigate a new vaccine leveraging the technology of Rocketvax. Emergent provides health solutions for threats such as anthrax, botulism, Ebola, mpox, opioid overdose emergencies and smallpox. Rocketvax focuses on developing next-generation vaccines using molecular biology technologies based on live attenuated viruses. Rocketvax CEO Dr Vladimir Cmiljanovic stated: 'By partnering with Emergent BioSolutions, we are combining cutting-edge vaccine innovation with world-class production and regulatory expertise. 'This joint venture not only accelerates the development of next-generation vaccines but also paves the way for groundbreaking advancements in global healthcare. Our shared vision is to revolutionise disease prevention and immunotherapy, bringing life-saving solutions to millions worldwide. 'By joining forces with Emergent, we can leverage their world-class production capabilities to deliver next-generation vaccines that have the potential to transform disease prevention and immunotherapy.' In August 2024, Emergent received US Food and Drug Administration (FDA) approval for its supplemental biologics licence application for ACAM2000, expanding its use to include the prevention of mpox. "Emergent signs financial investment agreement with Swiss Rockets" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Associated Press
10-03-2025
- Business
- Associated Press
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 10, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading global contract research, development, and manufacturing organization, for a total value of $36.5 million. The Bayview site includes manufacturing, laboratory, warehousing and office space, and is fitted with multiple monoclonal antibody (mAbs) manufacturing lines. As part of the agreement, Emergent will retain the rights to secure manufacturing services and capacity at the facility for future growth and pandemic response production in collaboration with Syngene. Emergent continues to operate a streamlined manufacturing network, including facilities in Lansing, Michigan and Winnipeg, Manitoba, Canada capable of serving strategic partners and supporting large-scale projects. 'The sale of Bayview represents a continuation of our efforts to deliver on our multi-year transformation plan and creates a streamlined, customer-focused, leaner, more flexible organization that provides the capabilities to deliver our product demand today and into the future,' said Joe Papa, president and CEO of Emergent. 'Now in our turnaround phase, we see significant opportunities for Emergent's core products and future growth drivers that have the potential to protect and save countless lives.' In March 2024, Emergent received a favorable inspection outcome, 'No Action Indicated' or NAI status classification from the U.S. Food and Drug Administration (FDA) for the Bayview site. Emergent remains committed to ensuring continued compliance with Current Good Manufacturing Practices (CGMP) requirements and delivering high-quality products for communities around the world. Papa added, 'Thanks to the hard work and dedication of colleagues across Emergent, we have strengthened operational quality and compliance systems across our network to continue to uphold the highest standards of patient safety, quality, and compliance in our work every day.' The agreement with Syngene International includes a transfer of assets and equipment associated with the Baltimore-Bayview facility. The sale is expected to close in the first quarter of 2025, subject to the satisfaction of customary closing conditions. For Emergent, Truist served as financial advisor, and Covington & Burling LLP served as legal counsel in connection with this transaction. About Emergent BioSolutions At Emergent, our mission is to protect and save lives. For over 25 years, we've been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today's health challenges and tomorrow's threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the expected timing for completion of the disposition of Emergent's Baltimore-Bayview facility, Emergent's ability to achieve the objectives of the disposition, including achieving improvement in cost structure and performance, and Emergent's future results, are forward-looking statements. We generally identify forward-looking statements by using words like 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'forecast,' 'future,' 'goal,' 'improve,' 'intend,' 'may,' 'plan,' 'position,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would,' and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events based on information that is currently available. We cannot guarantee that any forward-looking statements will be accurate. Readers should realize that if underlying assumptions prove inaccurate or if known or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statements. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake any obligation to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause Emergent's actual results to differ materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors and other disclosures included in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements. Investor Contact: Richard S. Lindahl Executive Vice President, CFO Media Contact: Assal Hellmer
Euronews
19-02-2025
- Entertainment
- Euronews
among friends: Milan's premier art fair miart will celebrate closeness
Milan's renowned modern and contemporary art fair – and Italy's largest, by exhibitor numbers – miart has revealed the plans for its 2025 edition. Running from 4-6 April as a driving force within Milan Art Week, miart's 29th edition will showcase 179 galleries from 30 countries across five continents, bringing together more than a century's worth of art under one roof. Under the artistic direction of Ricciardi, miart 2025 will present works from the 20th century through to today, spanning three main sections: Established, Emergent, and Portal. Art lovers will find everything from early modern masterpieces to cutting-edge contemporary pieces, with a special emphasis on the Italian artists who played a crucial role in shaping Milan's cultural legacy. International heavyweights participating in the Established section include Victoria Miro (London, Venice), MASSIMODECARLO (Milan, London, Hong Kong,Paris, Beijing), Ben Brown Fine Arts (London, Hong Kong, Venice), and Meyer Riegger (Berlin, Karlsruhe, Basel, Seoul). Curated by Attilia Fattori Franchini, Emergent, on the other hand, showcases the latest generation of artists, featuring 25 galleries from across the globe. Portal, curated for the first time by Alessio Antoniolli – Director of Triangle Network in London and curator at Fondazione Memmo in Rome – will, as Ricciardi tells Euronews Culture feature ten galleries, 'each presenting a monographic project that transcends disciplinary, temporal, and spatial boundaries' in order to 'unveil hidden narratives and explore new creative territories'. The title of the 2025 edition of miart, among friends, Ricciardi explains, stands as a tribute to the legacy of Robert Rauschenberg (1925-2008), marking the centenary of his birth. It also reflects the core values of his work: 'openness to the world, interdisciplinarity, and commitment to dialogue and collaboration'. 'Embracing the approach of the American artist, the fair aims, for its 29th edition, to energise the network of relationships built over the years, positioning itself as a driving force behind an ideal festival of contemporary arts for the city – that is, the Milano Art Week,' Ricciardi says. This commitment is reflected in a series of initiatives that celebrate "friendship" in the art world, 'understood as an equal, reciprocal, and genuinely supportive relationship among all the stakeholders in the art system'. For Ricciardi, this includes 'the fair, the institutions, galleries, artists, curators, collectors.' Among these initiatives is 'Rauschenberg e il Novecento' at the Museo del Novecento, which will explore Rauschenberg's legacy, linking his work to key Italian movements like Futurism and Arte Povera. Also bringing the theme to life will be the exhibition 'John Giorno: a Labour of LOVE at Triennale Milano', which will shine a light on American poet and performer John Giorno (1936–2019) and explore traces of his deep friendships and collaborations with major figures from 20th-century art, literature, and music, including Robert Rauschenberg, Keith Haring, Patti Smith, and Andy Warhol.
